Evidence map›Paper›PMID 30577816›Full record

ArticleBMC public health2018

Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme.

Nor Asiah Muhamad, Saidatul Norbaya Buang, Safurah Jaafar, Rohani Jais, Phaik Sim Tan, Normi Mustapha, Noor Aliza Lodz, Tahir Aris, Lokman Hakim Sulaiman, Shahnaz Murad

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 4 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 4 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Global determinants of gynecologic cancer incidence and mortality: A cluster-based analysis with predictive insights.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nor Asiah MuhamadInstitute for Public Health, Ministry of Health, Kuala Lumpur, Malaysia. norasiahdr@gmail.com.
Saidatul Norbaya BuangFamily Health Development Division, Ministry of Health, Kuala Lumpur, Malaysia.
Safurah JaafarFamily Health Development Division, Ministry of Health, Kuala Lumpur, Malaysia.
Rohani JaisDisease Control Division, Ministry of Health, Kuala Lumpur, Malaysia.
Phaik Sim TanFamily Health Development Division, Ministry of Health, Kuala Lumpur, Malaysia.
Normi MustaphaFaculty of Science and Technology, Open University Malaysia, Kuala Lumpur, Malaysia.
Noor Aliza LodzInstitute for Public Health, Ministry of Health, Kuala Lumpur, Malaysia.
Tahir ArisInstitute for Public Health, Ministry of Health, Kuala Lumpur, Malaysia.
Lokman Hakim SulaimanDepartment of Community Medicine, International Medical University, Kuala Lumpur, Malaysia.
Shahnaz MuradOffice of Deputy Director General of Health (Research and Technical Support), Ministry of Health, Putrajaya, Malaysia.
Ministry of Health · MYOpen University Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2006, 4 years of planning was started by the Ministry of Health, Malaysia (MOH), to implement the HPV (human papillomavirus) vaccination programme. An inter-agency and multi-sectoral collaborations were developed for Malaysia's HPV school-based immunisation programme. It was approved for nationwide school base implementation for 13-year-old girls or first year secondary students in 2010. This paper examines how the various strategies used in the implementation over the last 7 years (2010-2016) that unique to Malaysia were successful in achieving optimal coverage of the target population.

methodsFree vaccination was offered to school girls in secondary school (year seven) in Malaysia, which is usually at the age of 13 in the index year. All recipients of the HPV vaccine were identified through school enrolments obtained from education departments from each district in Malaysia. A total of 242,638 girls aged between 12 to 13 years studying in year seven were approached during the launch of the program in 2010. Approximately 230,000 girls in secondary schools were offered HPV vaccine per year by 646 school health teams throughout the country from 2010 to 2016.

resultsParental consent for their daughters to receive HPV vaccination at school was very high at 96-98% per year of the programme. Of those who provided consent, over 99% received the first dose each year and 98-99% completed the course per year. Estimated population coverage for the full vaccine course, considering also those not in school, is estimated at 83 to 91% per year. Rates of adverse events reports following HPV vaccination were low at around 2 per 100,000 and the majority was injection site reactions.

conclusionA multisectoral and integrated collaborative structure and process ensured that the Malaysia school-based HPV immunisation programme was successful and sustained through the programme design, planning, implementation and monitoring and evaluation. This is a critical factor contributing to the success and sustainability of the school-based HPV immunisation programme with very high coverage.

Indexed as

Immunization ProgramsSchool Health ServicesAdolescentChildFemaleHumansMalaysiaPapillomavirus VaccinesProgram EvaluationVaccinationPapillomavirus VaccinesCervical cancerHPVImmunisationMalaysiaSchool based

Identifiers

PMID30577816
PMCPMC6303856
OpenAlexW2906350926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.